← Leaderboards
Melanie G Cree
University Of Colorado Denver
$5,579,720
Attributed
$5,579,720
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,579,720 · 4
By mechanism
R01$4,280,837 · 2
K23$742,810 · 1
R21$556,073 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Nicole Renee Tartaglia$8,137,304
- Gary A Bellus$436,448
- Petter Bjornstad$9,008,713
- Nanette F. Santoro$20,812,570
- Gary J. Miller$1,880,510
Others in their field
Top investigators on “Glucose”
- David M Nathan · Massachusetts Institute Of Technology$150,714,133
- John M Lachin · George Washington University$140,240,809
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Rose A Gubitosi-Klug · Case Western Reserve University$72,189,325
- Jose A Luchsinger · Columbia University Health Sciences$60,179,866
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,218,842
Research focus
GlucoseAndrogensObesityHigh PrevalenceMetabolicAdultInsulinHypergravityWomanYouthPolycystic Ovary SyndromeAdolescenceGirlsNon-Insulin-Dependent Diabetes MellitusGlp-I ReceptorAgonistClinical TrialsOralDiabetes MellitusFutureNovel TherapeuticsComorbidityInsulin ResistanceInsulin Sensitivity
Grant awards (14)
Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome$526,747
R01 · FY2025 · HD · contact PI
Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome$528,380
R01 · FY2024 · HD · contact PI
The presentation and medical course of PCOS in adolescents across the United States$174,334
R21 · FY2024 · HD · contact PI
Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome$541,072
R01 · FY2023 · HD · contact PI
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome$464,830
R01 · FY2023 · DK · contact PI
The presentation and medical course of PCOS in adolescents across the United States$381,739
R21 · FY2023 · HD · contact PI
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome$542,337
R01 · FY2022 · DK · contact PI
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome$543,446
R01 · FY2021 · DK · contact PI
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome$569,139
R01 · FY2020 · DK · contact PI
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome$564,886
R01 · FY2019 · DK · contact PI
Influence of peripheral insulin resistance and hepatic lipogenesis on liver fat in obese PCOS girls$192,240
K23 · FY2018 · DK · contact PI
Influence of peripheral insulin resistance and hepatic lipogenesis on liver fat in obese PCOS girls$192,239
K23 · FY2017 · DK · contact PI
Influence of peripheral insulin resistance and hepatic lipogenesis on liver fat in obese PCOS girls$178,415
K23 · FY2016 · DK · contact PI
Influence of peripheral insulin resistance and hepatic lipogenesis on liver fat in obese PCOS girls$179,916
K23 · FY2015 · DK · contact PI